Dingjiang Liu

2.3k total citations
42 papers, 1.7k citations indexed

About

Dingjiang Liu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Dingjiang Liu has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Genetics. Recurrent topics in Dingjiang Liu's work include Protein purification and stability (19 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Protein Structure and Dynamics (7 papers). Dingjiang Liu is often cited by papers focused on Protein purification and stability (19 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Protein Structure and Dynamics (7 papers). Dingjiang Liu collaborates with scholars based in United States, Canada and Switzerland. Dingjiang Liu's co-authors include Daniel F. Wyss, David N. Brems, Da Ren, Mitsuhiko Ikura, Yu‐Sen Wang, Richard L. Remmele, Rieko Ishima, Ramil F. Latypov, Andrew Nichols and Stefan Bagby and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Dingjiang Liu

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingjiang Liu United States 19 1.5k 623 207 175 151 42 1.7k
Jeliazko R. Jeliazkov United States 13 1.3k 0.8× 496 0.8× 119 0.6× 67 0.4× 210 1.4× 21 1.6k
Sergey Lyskov United States 14 1.6k 1.1× 435 0.7× 123 0.6× 81 0.5× 215 1.4× 19 2.1k
Aaron K. Chamberlain United States 19 1.7k 1.1× 543 0.9× 94 0.5× 171 1.0× 249 1.6× 22 2.2k
Andrew A. Bogan United States 6 1.9k 1.3× 328 0.5× 198 1.0× 114 0.7× 157 1.0× 8 2.3k
C.-W. von der Lieth Germany 23 1.6k 1.0× 244 0.4× 466 2.3× 172 1.0× 235 1.6× 41 2.2k
Yoji Arata Japan 21 1.4k 0.9× 638 1.0× 94 0.5× 165 0.9× 357 2.4× 47 1.8k
Henryk Mach United States 19 1.0k 0.7× 253 0.4× 108 0.5× 74 0.4× 131 0.9× 34 1.4k
Kathleen L. Grant United States 8 1.1k 0.7× 286 0.5× 190 0.9× 51 0.3× 114 0.8× 11 1.6k
Jason W. Labonte United States 15 1.4k 0.9× 193 0.3× 198 1.0× 66 0.4× 57 0.4× 24 1.8k
James J. Havranek United States 17 1.5k 1.0× 189 0.3× 154 0.7× 71 0.4× 81 0.5× 25 1.7k

Countries citing papers authored by Dingjiang Liu

Since Specialization
Citations

This map shows the geographic impact of Dingjiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingjiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingjiang Liu more than expected).

Fields of papers citing papers by Dingjiang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingjiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingjiang Liu. The network helps show where Dingjiang Liu may publish in the future.

Co-authorship network of co-authors of Dingjiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dingjiang Liu. A scholar is included among the top collaborators of Dingjiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingjiang Liu. Dingjiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Dingjiang, et al.. (2025). Injection site reactions of biologics and mitigation strategies. SHILAP Revista de lepidopterología. 11(1). 2 indexed citations
3.
Li, Shuai, Shuli Tang, Yu Huang, et al.. (2024). Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mapping. Journal of Pharmaceutical and Biomedical Analysis. 251. 116452–116452. 5 indexed citations
4.
Chen, Yao, Shuai Li, Xiaoyan Wang, et al.. (2023). Lyophilization as an effective tool to develop AAV8 gene therapy products for refrigerated storage. International Journal of Pharmaceutics. 648. 123564–123564. 7 indexed citations
5.
Hu, Qingyan, James T. Wu, Yuan Cao, et al.. (2023). Characterization of Microbial Growth Potential in Antibody Drug IV Admixtures by Microbial Challenge. Journal of Pharmaceutical Sciences. 112(11). 2820–2833. 2 indexed citations
6.
Xu, Xiaobin, Yuan Cao, Matthew C. Franklin, et al.. (2022). Deciphering the High Viscosity of a Therapeutic Monoclonal Antibody in High Concentration Formulations by Microdialysis-Hydrogen/Deuterium Exchange Mass Spectrometry. Journal of Pharmaceutical Sciences. 111(5). 1335–1345. 2 indexed citations
7.
Jiang, Bowen, et al.. (2022). Genome DNA leakage of Adeno–Associated virus under freeze–thaw stress. International Journal of Pharmaceutics. 615. 121464–121464. 21 indexed citations
8.
Luo, Lin, Bowen Jiang, Yuan Cao, et al.. (2020). A hydrophobic interaction chromatography method suitable for quantitating individual monoclonal antibodies contained in co-formulated drug products. Journal of Pharmaceutical and Biomedical Analysis. 193. 113703–113703. 6 indexed citations
9.
Crotts, George, Christine Wurth, Valentyn Antochshuk, et al.. (2017). An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies. Journal of Pharmaceutical Sciences. 107(2). 529–542. 4 indexed citations
10.
Cao, Wenjin, Sampathkumar Krishnan, Margaret Speed Ricci, et al.. (2013). Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies. European Journal of Pharmaceutics and Biopharmaceutics. 85(2). 287–293. 51 indexed citations
11.
Yu, Lei, et al.. (2012). Identification and quantification of Fc fusion peptibody degradations by limited proteolysis method. Analytical Biochemistry. 428(2). 137–142. 6 indexed citations
12.
Kim, Nayoung, Richard L. Remmele, Dingjiang Liu, et al.. (2012). Aggregation of anti-streptavidin immunoglobulin gamma‐1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration. Biophysical Chemistry. 172. 26–36. 77 indexed citations
13.
Latypov, Ramil F., Dingjiang Liu, Kannan Gunasekaran, et al.. (2008). Structural and thermodynamic effects of ANS binding to human interleukin‐1 receptor antagonist. Protein Science. 17(4). 652–663. 38 indexed citations
14.
Latypov, Ramil F., Timothy S. Harvey, Dingjiang Liu, et al.. (2007). Biophysical Characterization of Structural Properties and Folding of Interleukin-1 Receptor Antagonist. Journal of Molecular Biology. 368(4). 1187–1201. 14 indexed citations
15.
Liu, Dingjiang, Melanie J. Cocco, Da Ren, et al.. (2007). Assignment of backbone 1H, 13C and 15N resonances of human IgG1 Fc (51.4 kDa). Biomolecular NMR Assignments. 1(2). 233–235. 10 indexed citations
16.
Liu, Dingjiang, William T. Windsor, & Daniel F. Wyss. (2003). Double‐stranded DNA‐induced localized unfolding of HCV NS3 helicase subdomain 2. Protein Science. 12(12). 2757–2767. 7 indexed citations
17.
Liu, Dingjiang, Yu‐Sen Wang, Jennifer J. Gesell, & Daniel F. Wyss. (2001). Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase 1 1Edited by M. F. Summers. Journal of Molecular Biology. 314(3). 543–561. 14 indexed citations
18.
Bagby, Stefan, et al.. (2000). TFIIA–TAF regulatory interplay: NMR evidence for overlapping binding sites on TBP. FEBS Letters. 468(2-3). 149–154. 30 indexed citations
19.
20.
Liu, Dingjiang, Rieko Ishima, Stefan Bagby, et al.. (1998). Solution Structure of a TBP–TAFII230 Complex. Cell. 94(5). 573–583. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeliazko R. Jeliazkov Breakdown of academic impact, for papers by Sergey Lyskov Breakdown of academic impact, for papers by Aaron K. Chamberlain Breakdown of academic impact, for papers by Andrew A. Bogan Breakdown of academic impact, for papers by C.-W. von der Lieth Breakdown of academic impact, for papers by Yoji Arata Breakdown of academic impact, for papers by Henryk Mach Breakdown of academic impact, for papers by Kathleen L. Grant Breakdown of academic impact, for papers by Jason W. Labonte Breakdown of academic impact, for papers by James J. Havranek
Rankless by CCL
2026